Bio Green Med Solution (BGMS) Change in Accured Expenses (2011 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Change in Accured Expenses of -$535000.0 for Q1 2026, up 90.27% year-over-year from -$281178.0 in Q1 2025, and up 69.64% quarter-over-quarter from -$1.8 million in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Change in Accured Expenses for 16 consecutive years, with -$535000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 90.27% year-over-year to -$535000.0; the TTM figure through Mar 2026 stood at -$5.5 million (up 26.73% YoY), while the FY2025 annual figure was -$10.5 million, down 480.12% from the prior year.
- Change in Accured Expenses improved to -$535000.0 in Q1 2026 per BGMS's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2022 and bottomed at -$5.6 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged -$587000.0 across 5 years, with a median of -$407000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 477.89% — and 2025, when it tumbled 2264.96%.
- Bio Green Med Solution's Change in Accured Expenses stood at $2.8 million in 2022, then tumbled by 110.78% to -$303000.0 in 2023, then soared by 185.48% to $259000.0 in 2024, then plunged by 780.31% to -$1.8 million in 2025, then soared by 69.64% to -$535000.0 in 2026.
- Business Quant data shows BGMS's Change in Accured Expenses at -$535000.0 in Q1 2026, -$1.8 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.21 Bn | 133.36 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.88 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.17 Bn | 52.03 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.56 Bn | 44.56 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.56 Bn | 32.25 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.24 Bn | 27.40 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.23 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Bio Green Med Solution | 5.03 Mn | 1.24 Mn | 79,000.00 | -103,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -103,000.00 |
| Mar 31, 2026 | -535,000.00 |
| Dec 31, 2025 | -1.76 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | -5.50 Mn |
| Dec 31, 2024 | 259,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.18 Mn |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | -303,000.00 |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | -733,000.00 |
| Mar 31, 2023 | -206,000.00 |
| Dec 31, 2022 | 2.81 Mn |
| Sep 30, 2022 | -407,000.00 |
| Jun 30, 2022 | -913,000.00 |
| Mar 31, 2022 | 1.09 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 633,000.00 |